Clin2
NCT06011460Possibly a fitEnrolling by invitation

Observing clozapine safety for bipolar depression

Bipolar Disorder

Treatments studied

Part of Mental health clinical trials.

This study is testing whether clozapine, a medication usually used for schizophrenia, is safe for treating hard-to-treat depression in people with bipolar disorder. It may help if you have not found relief from other treatments.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
30 people
Ages
18 years to 65 years
Study type
Observational

Who can take part

  • You have bipolar disorder and are currently in a depressive episode that hasn't gotten better with other treatments.
  • You are between 18 and 65 years old.
  • You can understand and sign a consent form to participate.
  • You can follow the study's instructions, like taking medication and attending appointments.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07263191Recruiting
Olanzapine study for bipolar disorder

This study looks at how well patients with bipolar disorder do while taking the medication olanzapine. You will continue your regular treatment, and answer questions about your experience.

Seongnam
NCT04580134Recruiting· Phase 4
Clozapine study for people with a specific schizophrenia or bipolar type

This trial tests whether clozapine works better for people whose illness fits a specific “biotype-1” pattern. It may help reduce ongoing symptoms, but it also requires close safety monitoring.

Hartford, Connecticut
NCT05316883Recruiting· Phase 4
Testing blood markers in people on clozapine for schizophrenia

This study looks at “biomarkers,” or blood measures, in people with schizophrenia who respond to clozapine. It may help researchers understand who benefits from clozapine and why, by linking test results to symptom changes.

Glostrup Municipality, Denmark
NCT05208190Recruiting· Phase 4
Clozapine to prevent violence in schizophrenia

This trial tests whether clozapine can reduce repeat violent behavior in people with schizophrenia or schizoaffective disorder. Participants are randomly assigned to clozapine or usual care to see which approach works better for preventing violence.

Los Angeles, California
NCT04569448Recruiting· Phase 3
Brexpiprazole for bipolar depression that won’t improve

This Phase 3 study tests whether brexpiprazole can help treat bipolar depression that has not responded to previous treatments. It compares the study medicine to a placebo (inactive pill) for people with bipolar I or II depression.

Hamilton, Ontario
NCT06749041Not yet recruiting
Clozapine levels and side effects in treatment-resistant schizophrenia

This study looks at how the body processes clozapine (a medicine for schizophrenia) and its side effects, by checking blood levels at specific times. It aims to find the best time to draw blood for more accurate dosing and fewer side effects.

Hear when a new Bipolar Disorder trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.